GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Spectrum Pharmaceuticals, Inc. (SPPI) [hlAlert]

Rating:
Outperform
SPPI
down 11.46 %

Spectrum Pharmaceuticals, Inc. (SPPI) rated Outperform with price target $16 by RBC Capital Mkts

Posted on: Wednesday,  Mar 13, 2013  10:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) on 03/13/2013. Previously RBC Capital Mkts rated Outperform Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
on 03/25/2011., when the stock price was $8.46. Since then, Spectrum Pharmaceuticals, Inc. has lost 11.47% as of 12/04/2015's recent price of $7.49.
If you would have followed the previous RBC Capital Mkts's recommendation on SPPI, you would have lost 11.46% of your investment in 1715 days.

Spectrum Pharmaceuticals, Inc. ( Spectrum) is a commercial stage biopharmaceutical company, engaged in developing and commercializing therapies with a focus primarily in the areas of hematology-oncology and urology. The Company?s product is apaziquone (formerly EOquin), which is in two Phase 3 clinical trials for non-muscle invasive bladder cancer under a collaboration with Allergan Inc. Another drug, ozarelix is in a Phase 2 clinical trial for benign prostatic hypertrophy (BPH). On December 15, 2008, Spectrum and Cell Therapeutics, Inc. (CTI) partnered to form a joint venture, RIT Oncology, LLC (RIT), to develop Zevalin ([90Y]-ibritumomab tiuxetan) in the United States. Its subsidiaries include OncoRx Pharma Private Limited, Spectrum Pharmaceuticals GmbH, RIT Oncology, LLC and Spectrum Pharma Canada. During the year ended December 31, 2008, the Company dissolved NeoJB LLC.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/13/2013 10:25 AM Buy
None
7.92 16.00
as of 12/13/2013
1 Week down  -3.38 %
1 Month down  -1.93 %
3 Months up  13.71 %
1 YTD down  -18.49 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/25/2011 9:25 AM Buy
None
8.46 12.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy